| Published Application/Species/Sample/Dilution | Reference | 
|---|
| western blot; mouse; 1:500; loading ...; fig 5a
 | Kazuki Y, Gao F, Li Y, Moyer A, Devenney B, Hiramatsu K, et al . A non-mosaic transchromosomic mouse model of down syndrome carrying the long arm of human chromosome 21. elife. 2020;9: pubmed  publisher | 
| western blot; mouse; loading ...; fig 5c
 | Bruyère J, Abada Y, Vitet H, Fontaine G, Deloulme J, Ces A, et al . Presynaptic APP levels and synaptic homeostasis are regulated by Akt phosphorylation of huntingtin. elife. 2020;9: pubmed  publisher | 
| western blot; human; 1:2000; loading ...; fig 5h
 | Barros Viegas A, Carmona V, Ferreiro E, Guedes J, Cardoso A, Cunha P, et al . miRNA-31 Improves Cognition and Abolishes Amyloid-β Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer's Disease. Mol Ther Nucleic Acids. 2020;19:1219-1236 pubmed  publisher | 
| western blot; mouse; loading ...; fig 3e
 | Li J, Chiu J, Ramanjulu M, Blass B, Pratico D. A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles. Mol Neurodegener. 2020;15:1 pubmed  publisher | 
| western blot; human; loading ...; fig 1a
 | Jarosz Griffiths H, Corbett N, Rowland H, Fisher K, Jones A, Baron J, et al . Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-β oligomers. J Biol Chem. 2019;294:7085-7097 pubmed  publisher | 
| western blot; mouse; 1:50; loading ...; fig 1b
 | Tsatsanis A, Dickens S, Kwok J, Wong B, Duce J. Post Translational Modulation of β-Amyloid Precursor Protein Trafficking to the Cell Surface Alters Neuronal Iron Homeostasis. Neurochem Res. 2019;44:1367-1374 pubmed  publisher | 
| western blot; human; loading ...; fig 2bwestern blot; mouse; loading ...; fig 1c
 | Sun J, Carlson Stevermer J, Das U, Shen M, Delenclos M, Snead A, et al . CRISPR/Cas9 editing of APP C-terminus attenuates β-cleavage and promotes α-cleavage. Nat Commun. 2019;10:53 pubmed  publisher | 
| immunohistochemistry - paraffin section; mouse; loading ...; fig s7b
 | Atretkhany K, Mufazalov I, Dunst J, Kuchmiy A, Gogoleva V, Andruszewski D, et al . Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity. Proc Natl Acad Sci U S A. 2018;115:13051-13056 pubmed  publisher | 
|  | Meilandt W, Maloney J, Imperio J, Lalehzadeh G, Earr T, Crowell S, et al . Characterization of the selective in vitro and in vivo binding properties of crenezumab to oligomeric Aβ. Alzheimers Res Ther. 2019;11:97 pubmed  publisher | 
|  | Tambini M, Yao W, D ADAMIO L. Facilitation of glutamate, but not GABA, release in Familial Alzheimer's APP mutant Knock-in rats with increased β-cleavage of APP. Aging Cell. 2019;18:e13033 pubmed  publisher | 
|  | Suh J, Romano D, Nitschke L, Herrick S, DiMarzio B, Dzhala V, et al . Loss of Ataxin-1 Potentiates Alzheimer's Pathogenesis by Elevating Cerebral BACE1 Transcription. Cell. 2019;178:1159-1175.e17 pubmed  publisher | 
|  | Manogaran P, Samardzija M, Schad A, Wicki C, Walker Egger C, Rudin M, et al . Retinal pathology in experimental optic neuritis is characterized by retrograde degeneration and gliosis. Acta Neuropathol Commun. 2019;7:116 pubmed  publisher | 
|  | Götzl J, Brendel M, Werner G, Parhizkar S, Sebastian Monasor L, Kleinberger G, et al . Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism. EMBO Mol Med. 2019;: pubmed  publisher | 
|  | Grant M, Shapiro S, Ashe K, Liu P, Zahs K. A Cautionary Tale: Endogenous Biotinylated Proteins and Exogenously-Introduced Protein A Cause Antibody-Independent Artefacts in Western Blot Studies of Brain-Derived Proteins. Biol Proced Online. 2019;21:6 pubmed  publisher | 
|  | Bergner C, van der Meer F, Winkler A, Wrzos C, Türkmen M, Valizada E, et al . Microglia damage precedes major myelin breakdown in X-linked adrenoleukodystrophy and metachromatic leukodystrophy. Glia. 2019;67:1196-1209 pubmed  publisher | 
|  | Dinamarca M, Raveh A, Schneider A, Fritzius T, Früh S, Rem P, et al . Complex formation of APP with GABAB receptors links axonal trafficking to amyloidogenic processing. Nat Commun. 2019;10:1331 pubmed  publisher | 
|  | Chen X, Kordich J, Williams E, Levine N, Cole Strauss A, Marshall L, et al . Parkinson's disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration. Proc Natl Acad Sci U S A. 2019;116:5765-5774 pubmed  publisher | 
|  | Li J, Chiu J, Pratico D. Full recovery of the Alzheimer's disease phenotype by gain of function of vacuolar protein sorting 35. Mol Psychiatry. 2019;: pubmed  publisher | 
|  | Wimmer I, Scharler C, Zrzavy T, Kadowaki T, Mödlagl V, Rojc K, et al . Microglia pre-activation and neurodegeneration precipitate neuroinflammation without exacerbating tissue injury in experimental autoimmune encephalomyelitis. Acta Neuropathol Commun. 2019;7:14 pubmed  publisher | 
|  | Evans C, Thomas R, Freeman T, Hvoslef Eide M, Good M, Kidd E. Selective reduction of APP-BACE1 activity improves memory via NMDA-NR2B receptor-mediated mechanisms in aged PDAPP mice. Neurobiol Aging. 2019;75:136-149 pubmed  publisher | 
|  | Tsang J, Lee M, Chan T, Li J, Ni Y, Shao Y, et al . Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer. EBioMedicine. 2018;38:89-99 pubmed  publisher | 
|  | Heisler F, Pechmann Y, Wieser I, Altmeppen H, Veenendaal L, Muhia M, et al . Muskelin Coordinates PrPC Lysosome versus Exosome Targeting and Impacts Prion Disease Progression. Neuron. 2018;99:1155-1169.e9 pubmed  publisher | 
|  | Paschkowsky S, Recinto S, Young J, Bondar A, Munter L. Membrane cholesterol as regulator of human rhomboid protease RHBDL4. J Biol Chem. 2018;293:15556-15568 pubmed  publisher | 
|  | Sasaguri H, Nagata K, Sekiguchi M, Fujioka R, Matsuba Y, Hashimoto S, et al . Introduction of pathogenic mutations into the mouse Psen1 gene by Base Editor and Target-AID. Nat Commun. 2018;9:2892 pubmed  publisher | 
|  | Sulkava S, Muggalla P, Sulkava R, Ollila H, Peuralinna T, Myllykangas L, et al . Melatonin receptor type 1A gene linked to Alzheimer's disease in old age. Sleep. 2018;41: pubmed  publisher | 
|  | Fong L, Yang M, Dos Santos Chaves R, Reyna S, Langness V, Woodruff G, et al . Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid-β clearance in human astrocytes. J Biol Chem. 2018;293:11341-11357 pubmed  publisher | 
|  | Nagata K, Takahashi M, Matsuba Y, Okuyama Uchimura F, Sato K, Hashimoto S, et al . Generation of App knock-in mice reveals deletion mutations protective against Alzheimer's disease-like pathology. Nat Commun. 2018;9:1800 pubmed  publisher | 
|  | Ruiz Riquelme A, Lau H, Stuart E, Goczi A, Wang Z, Schmitt Ulms G, et al . Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression. Acta Neuropathol Commun. 2018;6:26 pubmed  publisher | 
|  | Chung J, Phukan G, Vergote D, Mohamed A, Maulik M, Stahn M, et al . Endosomal-Lysosomal Cholesterol Sequestration by U18666A Differentially Regulates Amyloid Precursor Protein (APP) Metabolism in Normal and APP-Overexpressing Cells. Mol Cell Biol. 2018;38: pubmed  publisher | 
|  | ULRICH J, Ulland T, Mahan T, Nyström S, Nilsson K, Song W, et al . ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med. 2018;215:1047-1058 pubmed  publisher | 
|  | Halon Golabek M, Borkowska A, Kaczor J, Ziolkowski W, Flis D, Knap N, et al . hmSOD1 gene mutation-induced disturbance in iron metabolism is mediated by impairment of Akt signalling pathway. J Cachexia Sarcopenia Muscle. 2018;9:557-569 pubmed  publisher | 
|  | Janova H, Arinrad S, Balmuth E, Mitjans M, Hertel J, Habes M, et al . Microglia ablation alleviates myelin-associated catatonic signs in mice. J Clin Invest. 2018;128:734-745 pubmed  publisher | 
|  | Rossi M, Saverioni D, Di Bari M, Baiardi S, Lemstra A, Pirisinu L, et al . Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature. Acta Neuropathol Commun. 2017;5:87 pubmed  publisher | 
|  | Lanchec E, Desilets A, Béliveau F, Flamier A, Mahmoud S, Bernier G, et al . The type II transmembrane serine protease matriptase cleaves the amyloid precursor protein and reduces its processing to β-amyloid peptide. J Biol Chem. 2017;292:20669-20682 pubmed  publisher | 
|  | Williamson R, Laulagnier K, Miranda A, Fernandez M, Wolfe M, Sadoul R, et al . Disruption of amyloid precursor protein ubiquitination selectively increases amyloid ? (A?) 40 levels via presenilin 2-mediated cleavage. J Biol Chem. 2017;292:19873-19889 pubmed  publisher | 
|  | Colvin B, Rogers V, Kulas J, Ridgway E, Amtashar F, Combs C, et al . The conformational epitope for a new A?42 protofibril-selective antibody partially overlaps with the peptide N-terminal region. J Neurochem. 2017;143:736-749 pubmed  publisher | 
|  | Mass E, Jacome Galarza C, Blank T, Lazarov T, Durham B, Ozkaya N, et al . A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease. Nature. 2017;549:389-393 pubmed  publisher | 
|  | Branca C, Shaw D, Belfiore R, Gokhale V, Shaw A, Foley C, et al . Dyrk1 inhibition improves Alzheimer's disease-like pathology. Aging Cell. 2017;16:1146-1154 pubmed  publisher | 
|  | Kulas J, Puig K, Combs C. Amyloid precursor protein in pancreatic islets. J Endocrinol. 2017;235:49-67 pubmed  publisher | 
|  | Mast N, Saadane A, Valencia Olvera A, Constans J, Maxfield E, Arakawa H, et al . Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease. Neuropharmacology. 2017;123:465-476 pubmed  publisher | 
|  | Liebsch F, Aurousseau M, Bethge T, McGuire H, Scolari S, Herrmann A, et al . Full-length cellular ?-secretase has a trimeric subunit stoichiometry, and its sulfur-rich transmembrane interaction site modulates cytosolic copper compartmentalization. J Biol Chem. 2017;292:13258-13270 pubmed  publisher | 
|  | Schultz V, van der Meer F, Wrzos C, Scheidt U, Bahn E, Stadelmann C, et al . Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination. Glia. 2017;65:1350-1360 pubmed  publisher | 
|  | Bussiere R, Lacampagne A, Reiken S, Liu X, Scheuerman V, Zalk R, et al . Amyloid ? production is regulated by ?2-adrenergic signaling-mediated post-translational modifications of the ryanodine receptor. J Biol Chem. 2017;292:10153-10168 pubmed  publisher | 
|  | Lagumersindez Denis N, Wrzos C, Mack M, Winkler A, van der Meer F, Reinert M, et al . Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis. Acta Neuropathol. 2017;134:15-34 pubmed  publisher | 
|  | Chapuis J, Flaig A, Grenier Boley B, Eysert F, Pottiez V, Deloison G, et al . Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism. Acta Neuropathol. 2017;133:955-966 pubmed  publisher | 
|  | Saab A, Tzvetavona I, Trevisiol A, Baltan S, Dibaj P, Kusch K, et al . Oligodendroglial NMDA Receptors Regulate Glucose Import and Axonal Energy Metabolism. Neuron. 2016;91:119-32 pubmed  publisher | 
|  | Chen A, Kim S, Shepardson N, Patel S, Hong S, Selkoe D. Physical and functional interaction between the α- and γ-secretases: A new model of regulated intramembrane proteolysis. J Cell Biol. 2015;211:1157-76 pubmed  publisher |